BNTC Earnings

Quarterly EPS
$-0.26
Q2 2025
$-0.33
Q4 2024
$-0.38
Q3 2025
$-0.21
Q4 2025
$-0.22
Q1 2026
$-0.26
Q2 2026
$-0.24
Q3 2026
$-0.26
Q4 2026
Latest RevenueN/A
Latest Net Income-12809000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q4 2026-$0.260-12809000-23.8%
Q3 2026-$0.240-11935000+36.8%
Q2 2026-$0.260-11837000+21.2%
Q1 2026-$0.220-8965000+15.4%
Q4 2025-$0.210-8805000-16.7%
Q3 2025-$0.380-14501000-65.2%
Q4 2024-$0.330-4720000+79.9%
Q2 2025-$0.260-9552000+90.2%
Q1 2025-$0.180-5059000
Q3 2024-$0.230-4279000
Q1 2024-$1.640-4279000
Q4 2023-$2.640-6798000
Benitec Biopharma (BNTC) — Earnings